Roche launches genomic profiling kit to expand personalised cancer research

 The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the

      first jointly-developed product that brings together the expertise and 
      reach of Roche with Foundation Medicine's pioneering leadership in 
      genomic science. 
 
   -- This is the first time that research scientists can conduct oncology 
      research with Foundation Medicine's comprehensive genomic profiling in 
      their own laboratories to gain meaningful genomic insights and deepen 
      their understanding of cancer biology. 
 
   -- This kit is an important step forward in Roche and Foundation Medicine's 
      vision of enabling personalised healthcare for more patients living with 
      cancer by broadening access to CGP and making it essential in clinical 
      decision making in the future. 

https://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-9364975/news/Press-Release-Roche-launches-comprehensive-genomic-profiling-kit-to-expand-access-to-personalised-36768638/